Clinical Trials Logo

Stroke clinical trials

View clinical trials related to Stroke.

Filter by:

NCT ID: NCT03875677 Recruiting - Stroke Clinical Trials

High-definition Transcranial Direct Current Stimulation for Facilitating Hand Function Recovery After Stroke

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

Transcranial direct current stimulation (tDCS) had recently been shown having feasibility in modulating cortical excitability transiently during motor training in a noninvasive way. The findings support that tDCS and motor practice can positively promote post-stroke motor learning to improve upper-limb motor recovery after stroke. A randomized controlled trial will be conducted with three groups: HD-tDCS, conventional tDCS and sham HD-tDCS. A 10-session training will be provided to evaluate the effectiveness of transient modulation of cortical excitability through tDCS with clinical assessment scores.

NCT ID: NCT03874702 Enrolling by invitation - Stroke Clinical Trials

Automated Diagnosis of Stroke in Computed Tomography With the Use of Artificial Intelligence

Start date: June 1, 2019
Study type: Observational [Patient Registry]

The use of the systems of machine learning for the quantification, location and diagnosis of ischemic stroke in non-contrasted head computed tomography, is a method with high efficacy, accessible and susceptible for standardization, for the assistance in the clinical decision making in the absence of specialized health personnel for the attention of this disease.

NCT ID: NCT03873467 Recruiting - Stroke Clinical Trials

Group Lifestyle Balance™ for Individuals With Stroke (GLB-CVA)

Start date: July 1, 2019
Phase: N/A
Study type: Interventional

The purpose of this RCT is to examine the efficacy of the Group Lifestyle Balance (GLB) program adapted for people with stroke (CVA) on primary (weight) and secondary outcomes at 3, 6, 12 months from enrollment into the program.

NCT ID: NCT03871517 Not yet recruiting - Ischemic Stroke Clinical Trials

INdobufen Versus aSpirin in acUte Ischemic stRokE,INSURE

Start date: May 1, 2019
Phase: Phase 4
Study type: Interventional

China has the largest burden of cerebrovascular disease in the world. About 60% to 80% of which are ischemic stroke. In recent years, stroke has replaced heart disease and tumor diseases as the first cause of death and disability in adult population. The primary purpose of this study is to evaluate the efficacy of indobufen treatment in reducing the risk of a 3-month new stroke (any type of stroke, including ischemic stroke and hemorrhagic stroke) for patients with moderate/severe ischemic stroke is not inferior to aspirin therapy.

NCT ID: NCT03870672 Not yet recruiting - Stroke Clinical Trials

rTMS Plus CCFES-mediated Functional Task Practice for Severe Stroke

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

This study is a necessary and important step in the development of a new therapy for upper limb functional recovery in patients with severe motor impairment. It is the first clinical trial of non-invasive brain stimulation (repetitive transcranial magnetic stimulation or rTMS) delivered to excite the undamaged hemisphere (specifically the contralesional higher motor cortices or cHMC) in stroke. Therefore, this study will determine whether the positive results obtained in our short-term pilot study can be made to last longer and produce functional benefits in severe patients with the application of brain stimulation in combination with long-term rehabilitation therapy. Rehabilitation therapy administered is called contralaterally controlled functional electrical stimulation (CCFES). Determining whether combining rTMS facilitating the cHMC with CCFES produces synergistic gains in functional abilities in severe patients is necessary for acceptance by the clinical community and to move this technology toward commercialization and widespread dissemination. The proposed study will determine whether the combination of rTMS facilitating the cHMC with CCFES produces greater improvements in upper extremity function in severe participants who are ≥6 months from stroke onset than the combination of rTMS facilitating the damaged hemisphere (specifically the ipsilesional primary motor cortex, iM1) and CCFES or the combination of sham rTMS and CCFES. The secondary purposes are to define which patients benefit most from the treatments, which may inform future device and treatment development and clinical translation, and to explore what distinct effects the three treatments have on the brain. To accomplish these purposes, we are conducting a clinical trial that enrolls severe stroke patients.

NCT ID: NCT03869879 Not yet recruiting - Stroke Clinical Trials

Mobility Rehab, a Therapist-assisted System for Gait Rehabilitation

Start date: March 15, 2019
Phase: N/A
Study type: Interventional

Phase II of this study includes a pragmatic clinical trial which will take place at Northwest Rehabilitation Associates (NWRA) in Salem, OR to verify the efficacy of the system in a physical therapy clinic.

NCT ID: NCT03869567 Recruiting - Stroke Clinical Trials

Cone Beam Computed Tomography Following Thrombectomy

Start date: February 11, 2019
Phase: N/A
Study type: Interventional

Cerebral haemorrhages following reperfusion treatments involve not only rupture of the blood-brain barrier, but also direct damage to vessels related to the equipment used and secondary toxicity to thrombolytics. The rupture of the blood-brain barrier which results from ischemia / reperfusion is responsible for stagnation of the contrast product on the exams performed after thrombectomy. It is difficult to distinguish hyperdensities related to the stagnation of contrast product and Hemorrhage on a conventional scanner. The reference imaging is the double energy scanner performed at the thrombectomy outlet. But no study directly compared the results of the flat panel with the cone beam CT performed in immediate post-thrombectomy. The investigators propose a direct comparison of the cone beam CT with the dual energy CT performed at the exit of thrombectomy.

NCT ID: NCT03869138 Completed - Stroke Clinical Trials

Alternative Therapies for Improving Physical Function in Individuals With Stroke

Start date: December 18, 2015
Phase: N/A
Study type: Interventional

Neurological impairment is a devastating disease for patients and their families and a leading cause of adult disability. Traditional rehabilitative therapies can help regain motor function and ameliorate disability. However, health care reimbursed rehabilitation is usually provided for up to 6 months post stroke (3 months in form of inpatient therapy and 3 months in outpatient therapy). There are increasing community and other facilities offering rehabilitation in form of conventional, recreational and alternative (Yoga, Tai-chi) therapy. However, implementation of these conventional therapy techniques in individuals with neurological disorder impairments is tedious, resource-intensive, and costly, often requiring transportation of patients to specialized facilities. Based on recent evidence suggesting significant benefits of repetitive, task-orientated training, investigators propose to evaluate the feasibility of an alternative dance and gaming based virtual dance and gaming based therapy to improve overall physical function of community-dwelling individuals with neurological impairments, compared to conventional therapeutic rehabilitation. This pilot study aims to systematically obtain pilot data on compliance and efficacy as well as performing power analysis and sample size calculation for developing it into a randomized controlled trial for extramural funding purposes. The objective of the study is to determine the safety, feasibility, compliance and efficacy of an alternative dance and gaming-based virtual gaming therapy to improve overall physical function of community-dwelling individuals with neurologically impairment and compare it to that of conventional rehabilitation and also to determine the gains in community participation and integration with longer-term compliance to the dance and gaming -based intervention.

NCT ID: NCT03868410 Recruiting - Stroke Clinical Trials

A Novel Approach for Brain Stimulation in Severe Stroke

Start date: April 1, 2019
Phase: Early Phase 1
Study type: Interventional

The long-term goal of this project is to develop upper limb rehabilitation interventions that can be utilized for stroke survivors, specifically survivors with more severe limitations in use of their affected upper limb. This study will utilize a novel method of non-invasive brain stimulation in conjunction with upper limb training given for 15 visits over a period of 5 weeks. The study will include the following site visits: - Eligibility Screening and Informed Consent Visit - An MRI visit - Two testing visits in which motor function of the upper limb and neurophysiology will be measured - Fifteen intervention visits during which patients will receive upper limb training in conjunction with non-invasive brain stimulation - Repeat testing of motor function of the upper limb and neurophysiology - Repeat MRI testing - A follow-up visit completed 3 months after the completion of interventions

NCT ID: NCT03868007 Not yet recruiting - Clinical trials for Acute Coronary Syndrome

Protective Effects of RIC in Elderly With Acute Ischemic Stroke Complicating Acute Coronary Syndrome

Start date: March 10, 2019
Phase: N/A
Study type: Interventional

Remote ischemic conditioning (RIC) is a noninvasive strategy in which one or more cycles of brief and transient limb ischemia confers protection against prolonged and severe ischemia in distant organs.This study aimed to investigate whether RIC is safe and effective in patients with AIS complicating ACS